1
|
Salunkhe JD, Pulidindi IN, Patil VS, Patil SV. Neurospora sp. Mediated Synthesis of Naringenin for the Production of Bioactive Nanomaterials. Bioengineering (Basel) 2024; 11:510. [PMID: 38790376 PMCID: PMC11117806 DOI: 10.3390/bioengineering11050510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2024] [Revised: 05/14/2024] [Accepted: 05/15/2024] [Indexed: 05/26/2024] Open
Abstract
The application of Neurospora sp., a fungus that commonly thrives on complex agricultural and plant wastes, has proven successful in utilizing citrus peel waste as a source of naringin. A UV-Vis spectrophotometric method proved the biotransformation of naringin, with an absorption maximum (λmax) observed at 310 nm for the biotransformed product, naringenin (NAR). Further verification of the conversion of naringin was provided through thin layer chromatography (TLC). The Neurospora crassa mediated biotransformation of naringin to NAR was utilized for the rapid (within 5 min) synthesis of silver (Ag) and gold (Au) nanoconjugates using sunlight to accelerate the reaction. The synthesized NAR-nano Ag and NAR-nano Au conjugates exhibited monodispersed spherical and spherical as well as polygonal shaped particles, respectively. Both of the nanoconjugates showed average particle sizes of less than 90 nm from TEM analysis. The NAR-Ag and NAR-Au nanoconjugates displayed potential enhancement of the antimicrobial activities, including antibacterial and nematicidal properties over either standalone NAR or Ag or Au NPs. This study reveals the potential of naringinase-producing Neurospora sp. for transforming naringin into NAR. Additionally, the resulting NAR-Ag and NAR-Au nanoconjugates showed promise as sustainable antibiotics and biochemical nematicides.
Collapse
Affiliation(s)
| | - Indra Neel Pulidindi
- Jesus’ Scientific Consultancy for Industrial and Academic Research (JSCIAR), Tharamani 600113, India
| | - Vikas Sambhaji Patil
- University Institute of Chemical Technology (UICT), Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon 425001, India;
| | - Satish Vitthal Patil
- School of Life Sciences, Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon 425001, India;
| |
Collapse
|
2
|
Ngangom L, Venugopal D, Pandey N. Investigation of Trifolium repens L. from the Indian Himalayan region as a phyto-therapeutic agent. Nat Prod Res 2024:1-11. [PMID: 38178604 DOI: 10.1080/14786419.2023.2299319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Accepted: 12/19/2023] [Indexed: 01/06/2024]
Abstract
Trifolium repens is a well-known herbaceous, perennial herb and has been extensively used in the traditional medicine system over the years. Various parts of the plant are traditionally used as a curative agent against several health ailments such as skin problems, wound healing, stomach disorders, sedative, fever, antiseptic, analgesic, expectorant, psoriasis and eczema. To maximise the plant's potential for usage in the future, the review also aims to update information about its significant pharmacological properties. The ethnomedicinal benefits of T. repens have been well studied; however, the facets of the plant have not been explored yet. The current review outlines several bioactive compounds quantified from T. repens and a few of them namely quercetin, kaempferol, myricetin, acacetin and linamarin, have been reported to have biological activities such as antibacterial, antifungal, antileishmanial, anti-inflammatory, antiaging and anti-hepatotoxic activities. A significant number of in vitro studies have been done on the plant extract, but little is known about the isolation and efficacy of the potent natural bioactive compounds of T. repens. The bioactive compounds in T. repens can be used for advanced drug development against various health disorders.
Collapse
Affiliation(s)
- Leirika Ngangom
- Department of Microbiology, Graphic Era (Deemed to be University), Dehradun, India
| | - Divya Venugopal
- Department of Microbiology, Graphic Era (Deemed to be University), Dehradun, India
| | - Neha Pandey
- Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, India
| |
Collapse
|
3
|
Mallineni SK, Sakhamuri S, Kotha SL, AlAsmari ARGM, AlJefri GH, Almotawah FN, Mallineni S, Sajja R. Silver Nanoparticles in Dental Applications: A Descriptive Review. Bioengineering (Basel) 2023; 10:327. [PMID: 36978718 PMCID: PMC10044905 DOI: 10.3390/bioengineering10030327] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Revised: 02/15/2023] [Accepted: 03/01/2023] [Indexed: 03/08/2023] Open
Abstract
Silver nanoparticles have been a recent focus of many researchers in dentistry, and their potential uses and benefits have drawn attention in dentistry and medicine. The fabrication and utilization of nanoscale substances and structures are at the core of the rapidly developing areas of nanotechnology. They are often used in the dental industry because they prevent bacteria from making nanoparticles, oxides, and biofilms. They also stop the metabolism of bacteria. Silver nanoparticles (AgNPs) are a type of zero-dimensional material with different shapes. Dentistry has to keep up with changing patient needs and new technology. Silver nanoparticles (AgNPs) can be used in dentistry for disinfection and preventing infections in the oral cavity. One of the most interesting metallic nanoparticles used in biomedical applications is silver nanoparticles (AgNPs). The dental field has found promising uses for silver nanoparticles (AgNPs) in the elimination of plaque and tartar, as well as the elimination of bacterial and fungal infections in the mouth. The incorporation of AgNPs into dental materials has been shown to significantly enhance patients' oral health, leading to their widespread use. This review focuses on AgNP synthesis, chemical properties, biocompatibility, uses in various dental fields, and biomaterials used in dentistry. With an emphasis on aspects related to the inclusion of silver nanoparticles, this descriptive review paper also intends to address the recent developments of AgNPs in dentistry.
Collapse
Affiliation(s)
- Sreekanth Kumar Mallineni
- Pediatric Dentistry, Dr. Sulaiman Al Habib Hospital, Ar Rayyan, Riyadh 14212, Saudi Arabia
- Division for Globalization Initiative, Liaison Center for Innovative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai 980-8575, Japan
- Center for Transdisciplinary Research (CFTR), Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College, Saveetha University, Chennai 600077, Tamil Nadu, India
| | - Srinivasulu Sakhamuri
- Department of Conservative Dentistry & Endodontics, Narayana Dental College and Hospital, Nellore 523004, Andhra Pradesh, India
| | - Sree Lalita Kotha
- Department of Basic Dental Sciences, College of Dentistry, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia
| | | | | | - Fatmah Nasser Almotawah
- Preventive Dentistry Department, Pediatric Dentistry Division, College of Dentistry, Riyadh Elm University, Riyadh 13244, Saudi Arabia
| | - Sahana Mallineni
- Department of Periodontology, Krishna Institute of Medical Sciences, Nellore 523001, Andhra Pradesh, India
| | - Rishitha Sajja
- Clinical Data Management, Global Data Management and Centralized Monitoring, Global Development Operations, Bristol Myers Squibb, Pennington, NJ 07922, USA
| |
Collapse
|
4
|
Nikam PB, Salunkhe JD, Marathe KR, Alghuthaymi MA, Abd-Elsalam KA, Patil SV. Rhizobium pusense-Mediated Selenium Nanoparticles-Antibiotics Combinations against Acanthamoeba sp. Microorganisms 2022; 10:microorganisms10122502. [PMID: 36557755 PMCID: PMC9785558 DOI: 10.3390/microorganisms10122502] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Revised: 12/05/2022] [Accepted: 12/12/2022] [Indexed: 12/23/2022] Open
Abstract
Severe ocular infections by Acanthamoeba sp. lead to keratitis, resulting in irreversible vision loss in immune-compromised individuals. When a protozoal infection spreads to neural tissues, it causes granulomatous encephalitis, which can be fatal. Treatment often takes longer due to the transition of amoeba from trophozoites to cyst stages, cyst being the dormant form of Acanthamoeba. A prolonged use of therapeutic agents, such as ciprofloxacin (Cipro), results in severe side effects; thus, it is critical to improve the therapeutic efficacy of these widely used antibiotics, possibly by limiting the drug-sensitive protozoal-phase transition to cyst formation. Owing to the biomedical potential of selenium nanoparticles (SeNPs), we evaluated the synergistic effects of ciprofloxacin and Rhizobium pusense-biogenic SeNPs combination. SeNPs synthesized using Rhizobium pusense isolated from root nodules were characterized using UV-Visible spectrophotometer, FT-IR, SEM with EDX, particle size analysis, and Zeta potential. The combination was observed to reduce the sub-lethal dose of Cipro, which may help reduce its side effects. The selenium and ciprofloxacin (SeNPs-Cipro) combination reduced the LC50 by 33.43%. The anti-protozoal efficacy of SeNPs-Cipro was found to transduce through decreased protozoal-cyst formations and the inhibition of the galactosidase and protease enzymes of trophozoites. Furthermore, high leakage of sugar, proteins, and amino acids during the SeNPs-Cipro treatment was one primary reason for killing the trophozoites. These experimental results may be helpful in the further pre-clinical evaluation of SeNPs-Cipro to combat protozoal infections. Future studies for combinations of SeNPs with other antibiotics need to be conducted to know the potential of SeNPs against antibiotic resistance in Acanthamoeba.
Collapse
Affiliation(s)
- Pradnya B. Nikam
- Department of Biochemistry, School of Life Sciences, Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon 425001, India
| | - Jitendra D. Salunkhe
- Department of Biochemistry, School of Life Sciences, Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon 425001, India
| | - Kiran R. Marathe
- Department of Biochemistry, School of Life Sciences, Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon 425001, India
| | - Mousa A. Alghuthaymi
- Biology Department, Science and Humanities College, Shaqra University, Alquwayiyah 11971, Saudi Arabia
| | - Kamel A. Abd-Elsalam
- Plant Pathology Research Institute, Agricultural Research Center, Giza 12619, Egypt
- Correspondence: (K.A.A.-E.); or (S.V.P.); Tel.: +91-0257-2257421–25 (S.V.P.)
| | - Satish V. Patil
- Department of Biochemistry, School of Life Sciences, Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon 425001, India
- Correspondence: (K.A.A.-E.); or (S.V.P.); Tel.: +91-0257-2257421–25 (S.V.P.)
| |
Collapse
|